Yokogawa Releases SU10 Single Cellome Unit for Use in Biological Research

▴ Yokogawa Releases SU10 Single Cellome Unit for Use in Biological Research
For the creation of a smart cell industry

Yokogawa Electric Corporation (TOKYO: 6841) announces that it has developed the SU10 Single Cellome Unit, a device that uses a nanopipette*1 to inject substances such as genes and drugs and aspirate intracellular materials at target locations in individual cells. Targeting the biological research market, the SU10 is being released on this date in Japan, with release in other markets such as the US to follow at a later date.

Through the development of such solutions, Yokogawa’s life innovation business is fostering the development of an industry centering on the use of smart cells, i.e. finely-designed, expression-controlled biological cells.


Development Background

Rapid advances in biotechnology are leading to the development of a bioeconomy that is expected to have a wide-ranging impact on fields ranging from agriculture to manufacturing and healthcare. One segment of this bioeconomy will be the smart cell industry, which will involve the manufacture of high-performance products such as biological medicines and replacements for petroleum-derived products using finely-designed, expression-controlled cellular organisms (smart cells). Smart cells are expected to bring about major changes in the energy and environmental industries as well as such fields as agriculture, manufacturing, and healthcare, and to solve a number of problems facing humanity.


In April 2018, Yokogawa established a Life Innovation Business Headquarters with the goal of promoting well-being for all. In addition to engaging in our existing life science and manufacturing solutions businesses targeting the pharmaceutical and food industries, the headquarters will work with our customers to develop new products and services that make use of Yokogawa’s core measurement, control, and information technologies, and provide one-stop solutions that revolutionize productivity throughout the pharmaceutical and food industry value chain, from basic research to manufacturing, logistics, and services.


There is keen interest within the cancer and immunology research fields in the use of single-cell analysis to clarify the causes of diseases and study pathological conditions, and this is expected to lead to advances in drug discovery research and the development of precision medicine and regenerative medicine. With the aim of fostering the development of a smart cell industry, Yokogawa has developed the SU10 for use by researchers in single-cell analysis.

Tags : #Yokogawa #Releasessu10 #Singlecellome #Biologicalresearch

About the Author


Team Medicircle

Related Stories

09 Nov

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for all.

View
26 Sep

What Every Parent Needs to Know About Autism and Pandemic Babies

Contrary to earlier fears, the study found no connection between pandemic-related stress or maternal COVID-19 infection and a rise in autism rates among babies born during the pandemic.

View
05 Aug

Lingering Shadows: The Unseen Battle with Long COVID

The study highlights the urgent need for continued research and development of effective treatments to alleviate the burden of long COVID on individuals and society.

View
31 Jul

COVID-19 Impact Resurfaces at Paris Olympics: Athletes Forced to Withdraw and Reinstated Precautions

The Paris Olympics, anticipated as the first post-pandemic Games, have faced unforeseen challenges due to a resurgence of COVID-19 cases among athletes.

View
30 Jul

Delhi High Court Orders Removal of Misleading Claims About Coronil by Baba Ramdev

Justice Bhambhani pointed out that promoting unverified claims about Coronil could harm the reputation of the ancient Ayurvedic system of medicine.

View
11 Mar

India’s Pharma and MedTech Sector Bolsters Self-Reliance Amidst Pandemic Challenges

India is poised to emerge as a global leader in pharmaceutical innovation and production, contributing significantly to healthcare resilience and sustainability on a global scale.

View
18 Nov

Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 Duty

The Madras High Court has not only rectified an apparent disparity but also championed the cause of fairness and equality. The ruling ensures that PG medicos, who played a crucial role in combating the COVID-19 pandemic, receive the recognition they deserve through the allocation of incentive marks.

View
28 Oct

Spike in Cases of Auto-Immune Disorders like Rheumatoid Arthritis Post-COVID

It looks like the Coronavirus infection has altered our immune system, leading to a variety of health problems like arthritis. Many Covid patients are now coming to us complaining of joint and body pain. We are especially seeing a rise in cases of rheumatoid arthritis among women between 30-50 years of age.

View
16 Feb

Mask made little or no difference in protecting against COVID-19, a study finds

A recent study, conducted by the UK-based Cochrane Review shows that wearing masks in the community probably made little or no difference in protecting against COVID-19.

View
16 Jun

Precautions and prevention for dengue fever

Dengue fever is a painful, debilitating mosquito-borne disease caused by any one of four closely related dengue viruses. These viruses are related to the viruses that cause West Nile infection and yellow fever.

View

-Advertisements-




Trending Now

1.5 Million Bottles Recalled: Is Your ADHD Medication Safe?March 03, 2025
Dressed for Trust: Why Doctors Must Wear White Aprons AgainMarch 03, 2025
India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?March 01, 2025
Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?March 01, 2025
Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian KitchensMarch 01, 2025
Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025